尼格拉病理学有助于帕金森病中状和额头道的微观结构完整性
Chen-Pei Lin1,2, Lydian E J Knoop1, Irene Frigerio1,2
1Department of Anatomy and Neurosciences, Section Clinical Neuroanatomy and Biobanking, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
概括
扩散MRI揭示了帕金森病 (PD) 大脑中的微观结构变化. 黑色物质 (SN) 和其连接的这些变化与多巴胺基损失和莱维神经元积累相关.
科学领域:
- 神经成像是一种神经成像.
- 神经病理学神经病理学
- 运动障碍 运动障碍
背景情况:
- 帕金森病 (PD) 涉及由于多巴胺功能障碍和黑色物质 (SN) 退化而导致的运动和认知缺陷.
- 扩散MRI (dMRI) 可以检测到SN微结构变化,但其病理基础需要澄清.
研究的目的:
- 在PD中研究SN及其通道中微观结构变化的病理基质.
- 为了将dMRI发现与PD的神经病理标志物的相关性.
主要方法:
- 尸检后的dMRI和组织病理学测试对来自PD,PDD/DLB和对照捐赠者的脑样本进行.
- 使用免疫组织化学量化尼格拉尔勒维病理和多巴胺变性退化.
- 在SN及其区域中分析了平均扩散率 (MD) 和分数异构性 (FA).
主要成果:
- 与对照组相比,PD和PDD/DLB显示SN和SN-DLPFC通道MD增加,SN-尾状核通道FA增加.
- 增加的SN MD和SN-caudate核通道FA与多巴胺类损失相关.
- 增加SN-DLPFC通道的MD与Lewy神经细胞负载有关.
结论:
- dMRI检测了SN及其在PD,PDD和DLB的轨道中的微观结构变化.
- 这些dMRI变化与SN多巴胺变性退化和莱维神经元病理学有差异性关联.
- 这项研究将体内成像发现与PD频谱障碍的死后神经病理学联系起来.
更多相关视频
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
10.7K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.6K
相关概念视频
Parkinson's Disease: Overview
607
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
607
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
